2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

There is a new and promising form of treatment for those suffering from Parkinson’s Disease and it could be as simple as ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Favorable capital market conditions last week enabled the company to raise over $15 million from secondary offerings, and the proceeds allow the Company to fund fully the costs of this upcoming ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

The research team suggests that the treatment can help address very early stages of a condition such as Alzheimer’s or ...

In the future, the discovery may be used in treatment for Parkinson's ... Jan. 23, 2024 — Scientists argue that Parkinson's disease complexity demands a new way of classifying the disease for ...

Blind, Randomized, Placebo-controlled, Study of Bezisterim in Subjects with Early Parkinson’s Disease is now fully funded. Favorable capital market conditions last week enabled the company to raise ...